Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation.
- DOI
- 10.1002/cncr.33826
- Published
- 2021 Dec 1
- Container
- Cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/cncr.33826,
title = {Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation.},
author = {Warlick ED and Ustun C and Andreescu A and Bonagura AF and Brunner A and Chandra AB and Foran JM and Juckett MB and Kindwall-Keller TL and Klimek VM and Pease DF and Steensma DP and Waldman BM and Horowitz MM and Burns LJ and Khera N},
year = {2021},
journal = {Cancer},
doi = {10.1002/cncr.33826},
url = {https://doi.org/10.1002/cncr.33826}
}RIS
TY - JOUR TI - Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation. AU - Warlick ED AU - Ustun C AU - Andreescu A AU - Bonagura AF AU - Brunner A AU - Chandra AB AU - Foran JM AU - Juckett MB AU - Kindwall-Keller TL AU - Klimek VM AU - Pease DF AU - Steensma DP AU - Waldman BM AU - Horowitz MM AU - Burns LJ AU - Khera N PY - 2021 JO - Cancer DO - 10.1002/cncr.33826 UR - https://doi.org/10.1002/cncr.33826 ER -
APA
ED, W., C, U., A, A., AF, B., A, B., AB, C., JM, F., MB, J., TL, K., VM, K., DF, P., DP, S., BM, W., MM, H., LJ, B., & N, K. (2021). Blood and Marrow Transplant Clinical Trials Network Study 1102 heralds a new era in hematopoietic cell transplantation in high-risk myelodysplastic syndromes: Challenges and opportunities in implementation.. Cancer. https://doi.org/10.1002/cncr.33826
Source records
- pubmed · retrieved 2026-09-25T22:20:19.334Z